PCK1 and neoplasm: To determine whether upregulated PEPCK1 enhances mTOR/TOR signaling and thus promotes tumor growth under HDS conditions, we assessed mTOR/TOR signaling activity using pS6 antibody, a specific antibody against phosphorylated Ribosomal protein S6 (RpS6) [36], in tumor cells.